Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in multiple sclerosis patients.
Kent
S C
SC
Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Fukaura
H
H
Pietrusewicz
M J
MJ
Khoury
S J
SJ
Weiner
H L
HL
Hafler
D A
DA
D000284:Administration, Oral; D000818:Animals; D002460:Cell Line; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D004676:Myelin Basic Protein / Q000008:administration & dosage* / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
D016207:Cytokines; D004676:Myelin Basic Protein; D016212:Transforming Growth Factor beta